 Wakefulness-Promoting Agents
"Wakefulness-Promoting Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES.
| Descriptor ID |
D064690
|
| MeSH Number(s) |
D27.505.954.427.220.612
|
| Concept/Terms |
Wakefulness-Promoting Agents- Wakefulness-Promoting Agents
- Agents, Wakefulness-Promoting
- Wakefulness Promoting Agents
- Wake-Promoting Substances
- Substances, Wake-Promoting
- Wake Promoting Substances
- Wake-Promoting Drugs
- Drugs, Wake-Promoting
- Wake Promoting Drugs
- Wake-Promoting Agents
- Agents, Wake-Promoting
- Wake Promoting Agents
- Eugeroic Drugs
- Drugs, Eugeroic
|
Below are MeSH descriptors whose meaning is more general than "Wakefulness-Promoting Agents".
Below are MeSH descriptors whose meaning is more specific than "Wakefulness-Promoting Agents".
This graph shows the total number of publications written about "Wakefulness-Promoting Agents" by people in this website by year, and whether "Wakefulness-Promoting Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Wakefulness-Promoting Agents" by people in Profiles.
-
Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. Survivorship: cognitive function, version 1.2014. J Natl Compr Canc Netw. 2014 Jul; 12(7):976-86.
-
Greve DN, Duntley SP, Larson-Prior L, Krystal AD, Diaz MT, Drummond SP, Thein SG, Kushida CA, Yang R, Thomas RJ. Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study. J Clin Sleep Med. 2014 Feb 15; 10(2):143-53.
-
Harsh J, Yang R, Hull SG. The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder. Curr Med Res Opin. 2014 May; 30(5):945-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|